Pre-GFD | Post-GFD | Change (%) | P | |
---|---|---|---|---|
TPs (scale 0–18) | 16.3 (2.4) | 8.0 (1.6) | 8.3 (51) | < 0.001 |
FIQ (scale 0–80) | 74.3 (2.9) | 36.6 (4.0) | 37.7 (51) | < 0.001 |
HAQ (scale 0–3) | 1.7 (0.6) | 0.7 (0.3) | 1.0 (52) | < 0.001 |
VAS digestive (scale 0–100) | 47.8 (2.4) | 19.1 (0.8) | 28.7 (60) | < 0.001 |
VAS pain (scale 0–10) | 8.0 (0.5) | 3.9 (1.0) | 4.1 (52) | < 0.001 |
VAS fatigue (scale 0–10) | 7.9 (0.3) | 3.9 (0.8) | 4.0 (51) | < 0.001 |
SF36-PCS (scale 0–100) | 27.4 (3.6) | 40.4 (5.1) | +13.0 (48) | < 0.001 |
SF36-MCS (scale 0–100) | 17.4 (2.9) | 27.8 (3.3) | +10.4 (60) | < 0.001 |
Prescribed drugs (N) | 6.6 (1.5) | 3.3 (0.5) | 3.6 (55) | < 0.001 |
tTG2 (U/ml) | 60.4 (52.2) | 0.7 (0.2) | 59.7 (98) | < 0.05 |